Company Filing History:
Years Active: 1986-2009
Title: Nobuhiro Ikei: Innovator in Pyrimidine Metabolism and Gastric Function Evaluation
Introduction
Nobuhiro Ikei is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmacology, particularly in the areas of pyrimidine metabolism and gastric function evaluation. With a total of 5 patents to his name, Ikei's work has the potential to impact clinical practices and patient care.
Latest Patents
Ikei's latest patents include innovative methods for determining pyrimidine metabolic capacity. This invention provides a method for measuring and assessing an individual's ability to metabolize various fluorouracil drugs, such as 5-fluorouracil. The method involves administering a preparation containing a pyrimidine compound labeled with an isotope and assessing the in vivo metabolic capacity based on the behavior of an excreted metabolite. Another notable patent focuses on preparations for evaluating the eliminative ability of the stomach. This invention allows for the noninvasive evaluation of gastric emptying rates, which can be crucial for diagnosing gastric motor function and assessing the therapeutic effects of drugs.
Career Highlights
Nobuhiro Ikei is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his research and innovations. His work is instrumental in developing new methodologies that enhance the understanding of drug metabolism and gastric function.
Collaborations
Ikei collaborates with esteemed colleagues, including Makoto Inada and Hideji Nonomura. Their combined expertise contributes to the advancement of research in their respective fields.
Conclusion
Nobuhiro Ikei's contributions to the fields of pyrimidine metabolism and gastric function evaluation highlight his role as an influential inventor. His innovative patents pave the way for improved clinical practices and patient outcomes.